Rocket One Inc. Expands ATM Offering by $6.8M, Potentially Adding 26% Dilution
Summary
Rocket One Inc. expanded its ATM offering by an additional $6.829 million, a move critical for funding its new AI pivot but highly dilutive for current shareholders.
Key Events · Financing and Capital Events · HOTH
-
Increased ATM Program
Rocket One Inc. increased its At-The-Market (ATM) offering program by an additional $6.829 million. This brings the total potential sales under the existing Sales Agreement (dated November 8, 2024) to approximately $16.1 million, including $9.279 million already sold.
-
Significant Potential Dilution
The newly authorized $6.829 million represents approximately 26.25% of the company's current market capitalization, indicating substantial potential dilution for existing shareholders.
-
Addresses Liquidity Needs Amidst Pivot
This capital raise is critical for the company, which recently pivoted to AI semiconductor infrastructure and continues to face severe financial distress, including a going concern warning from its auditor.
Analysis · HOTH · Life Sciences
Rocket One Inc. (formerly Hoth Therapeutics), which recently pivoted to AI semiconductor infrastructure, significantly increased its At-The-Market (ATM) offering program by an additional $6.829 million. This substantial capital raise is critical for the company's liquidity, especially given its severe financial distress and a prior going concern warning. However, the additional offering represents approximately 26.25% of the current market capitalization, indicating a high potential for further dilution for existing shareholders.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HOTH was trading at $1.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $26M. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.